Table 2

Clinical and laboratory data of enrolled women according to the class of infection.

Variables

Ctrl

(PfHRP2-)

Total

(PfHRP2+)

NP

Past I

Acute I

Chronic I

No. of women

14

40

10

10

10

10

Primigravidae n (%)

4 (28)

13 (32.5)

3 (30)

3 (30)

3 (30)

4 (40)

Secundigravidae n (%)

5 (36)

13 (32.5)

3 (30)

3 (30)

3 (30)

3 (30)

Multigravidae n (%)

5 (36)

14 (35)

4 (40)

4 (40)

4 (40)

3 (30)

Age (years)

24.6 ± 1.6

25.6 ± 1.13

25.2 ± 2.3

26.6 ± 0.6

26.0 ± 1.96

24.8 ± 2.3

Pregnancy duration, weeks

40.8 ± 1.2

40.5 ± 2.6

41.1 ± 1.1

40.9 ± 0.9

41.1 ± 1.1

41.3 ± 1.3

Birth weight (g)

3,153 ± 93

2,723 ± 93*

2,995 ± 137

2,623 ± 131*

2,862 ± 167

2,411 ± 251*

Haemoglobin (g/dl)

11.9 ± 0.3

9.4 ± 2.5*

10.2 ± 1.2

8.5 ± 0.4*

8.4 ± 1.1*

10.2 ± 0.9

Parasitaemia, Venous

0

83%

0

0

205.5%

35.3%

Parasitaemia, Placental

0

294%

0

0

644.5%

%

(*) means significant when compared with the control group (p < 0.05)

NP (no parasites): PfHRP2 positive placenta without parasites or pigment detected by microscopy; PI (past infection): only pigment detected by microscopy; AI (acute infection): only parasites detected; CI (chronic infection): parasites and pigment detected; control (Ctrl): uninfected women with PfHRP2 negative placenta. Data are mean ± SE. Parasitaemia are expressed as parasites per 100 leukocytes. (*) significant difference with control group (p < 0.01 Mann Whitney U test).

Sarr et al. Malaria Journal 2010 9:45   doi:10.1186/1475-2875-9-45